Regulation and Restraint in Contemporary Medicine in the UK and USA

Front Matter....Pages i-viii
Front Matter....Pages 1-1
Regulation of the Discovery, Development and Supply of New Drugs: Lessons for Medicine....Pages 3-12
Trends in Regulation of the Profession in the United Kingdom....Pages 13-19
The Changing State of the Law in Relation to Product Liability in the United States of America....Pages 21-28
The Changing State of the Law in Relation to Product Liability in the United Kingdom....Pages 29-44
Front Matter....Pages 45-45
The Effects of Regulation on the Discovery, Supply and Cost of New Drugs....Pages 47-51
Economic Restraints on Research and Development in the Pharmaceutical Industry....Pages 53-73
Patient Demand and the Media....Pages 75-79
The Problems of Constraint Through the Influence of Lay Pressure Groups....Pages 81-97
Front Matter....Pages 99-99
Regulatory Trends in Early Clinical Trials....Pages 101-109
The Role of Long Term Surveillance, Especially of Vulnerable Groups of Patients....Pages 111-114
How Far are Results from Experimental Models Relevant?....Pages 115-117
The Problem of Safety Warnings to Patients and Subjects of Medical Research....Pages 119-134
Front Matter....Pages 135-135
Current Problems of Restraint in General Practice....Pages 137-143
Prescription Drug Abuse: Magnitude and Control....Pages 145-155
Flexibility or Rigidity in Specialist Training....Pages 157-160
The Increasing Practice of Defensive Medicine....Pages 161-173
Front Matter....Pages 175-175
How Much Regulation is Desirable in Industry?....Pages 177-182
How Much Regulation is Desirable in Clinical Practice?....Pages 183-188
How Much Regulation is Desirable in Hospital Practice?....Pages 189-193
The Future of Regulation: New Forces and New Expectations....Pages 195-205